Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJourneo Regulatory News (JNEO)

Share Price Information for Journeo (JNEO)

Share Price is delayed by 15 minutes
Get Live Data
440.00    -7.50 (-1.68%)
Bid:
435.00
Ask:
445.00
Spread: 10.00 (2.299%)
Market Cap: £77.77m
JNEO Live PriceLast checked at - London Stock Exchange

Intraday Journeo Share Chart

Holding(s) in Company

4 Apr 2013 12:01

RNS Number : 5887B
21st Century Technology PLC
04 April 2013
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

21ST CENTURY TECHNOLOGY PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

HARGREAVE HALE LIMITED

4. Full name of shareholder(s)  (if different from 3.):iv

DISCRETIONARY CLIENTS

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

02 APRIL 2013

6. Date on which issuer notified:

04 APRIL 2013

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB0008866310

142,500

142,500

7,542,500

7,542,500

8.0894%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

7,542,500

8.0894%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

7,400,000 of these shares are held for a unit trust operated by Marlborough Fund Managers Ltd for whom Hargreave Hale Ltd manages the investments on a discretionary basis. The remaining balance is held on behalf of other discretionary clients.

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

David Clueit

15. Contact telephone number:

01253 754739

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGUUUCUPWGGC
Date   Source Headline
26th May 20262:10 pmRNSHolding(s) in Company
7th May 20261:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSUS$1.2 million Purchase Order
28th Apr 202611:54 amRNSResult of AGM
23rd Apr 20267:00 amRNS£1.0m Infrastructure Protection Contracts
13th Apr 20267:00 amRNS£1.7m Purchase Orders for Information Systems
31st Mar 20267:00 amRNS£2.4m Contract Awards – Infrastructure Protection
24th Mar 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSNotice of Results and Investor Presentation
16th Mar 20267:00 amRNS-RContract award in Denmark
16th Mar 20267:00 amRNS-RContract award in Denmark
21st Jan 20267:00 amRNSTrading Update
12th Jan 20267:00 amRNSPurchase Orders
8th Dec 20257:00 amRNS£2.3m Purchase Orders – Infrastructure Protection
1st Dec 20254:25 pmRNSOption Exercise, Issue of Equity & PDMR Dealings
29th Oct 20257:00 amRNS$5m purchase orders for New York Subway
15th Oct 20254:02 pmRNSOption Exercise, Issue of Equity & PDMR Dealings
10th Oct 20259:45 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSPurchase Orders
25th Sep 20257:00 amRNSHalf-year Report
18th Sep 20257:00 amRNSPurchase Order
8th Sep 20257:00 amRNS-RNotice of Results & Investor Presentation
8th Sep 20257:00 amRNSFramework Agreement
2nd Sep 20257:00 amRNSAcquisition of Crime and Fire Defence Systems
1st Sep 20257:00 amRNS£3.5m Framework Agreement
27th Aug 20257:00 amRNS£1m Purchase Orders and airport systems extension
29th Jul 20257:00 amRNSTrading Update
16th Jul 20257:00 amRNS-RContract award in Denmark
10th Jul 20252:28 pmRNSHolding(s) in Company
19th Jun 20257:00 amRNSPurchase Order
5th Jun 20252:09 pmRNSDirector/PDMR Shareholding
29th May 20257:00 amRNS£4.2m Rail Systems Purchase Order
14th May 20257:00 amRNS£10m Framework Agreement
23rd Apr 202512:30 pmRNSResult of AGM
16th Apr 20257:00 amRNSPurchase Order
26th Mar 20259:54 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSFinal Results
21st Mar 20253:08 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSNotice of Results & Investor Presentation via IMC
18th Feb 202510:55 amRNSHolding(s) in Company
31st Jan 202511:09 amRNSHolding(s) in Company
29th Jan 20254:52 pmRNSIssue of Equity
29th Jan 202511:33 amRNSHolding(s) in Company
23rd Jan 202510:55 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSIssue of Equity and PDMR Dealings
20th Jan 20257:00 amRNSPurchase Order
14th Jan 20257:00 amRNSTrading Update
10th Jan 202511:16 amRNSHolding(s) in Company
7th Jan 20257:00 amRNSContract Award
17th Dec 20241:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.